Skip to main navigation

Top Menu

About Us
Our Science
Pipeline
Partnering
Investors & Media
Careers
Contact

Investors & Media

Events & Presentations

Past Events

39th Annual Cowen Healthcare Conference

Mar 11, 2019 at 2:50 PM EDT

Listen to webcast

CEO Dr. Manos Perros discusses the current landscape of antibiotic development during the BIO CEO & Investor Conference Panel, "Removing Commercialization Barriers for New Antimicrobial Drugs"

Feb 11 - Feb 12, 2019

Supporting Materials

View video clip 19.3 MB

BIO CEO & Investor Conference

Feb 11 - Feb 12, 2019

Panel "Removing Commercialization Barriers for New Antimicrobial Drugs"

Supporting Materials

View video clip 19.3 MB

Location

New York, NY

BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

Dec 12, 2018 at 1:40 PM EST

Listen to webcast

Supporting Materials

Entasis Therapeutics BMO 2018 Presentation 1.4 MB

Presentations

More information is coming soon.

Toolkit

Print page
RSS Feeds
Email Alerts
Search

Investor Relations

Corporate Overview
News & Events
- Press Releases
- Events & Presentations
Stock Information
SEC Filings
Corporate Governance
Investor Resources

"Antibiotic resistance is a worldwide problem that is constantly growing. New forms of resistance can spread quickly and across continents. At Entasis, we discover and develop novel antibacterials to address the serious medical need posed by multi-drug resistant bacterial infections."

— Ruben Tommasi, Chief Scientific Officer

©2019 Entasis Therapeutics Inc.

Terms of Use | Privacy Policy